Login / Signup

French national addictovigilance follow-up of zolpidem between 2014 and 2020: evolution of drug abuse, misuse and dependence before and after the regulatory change.

Aurélie AquizerateEdouard-Jules LaforgueMarion IstvanMorgane RousseletMarie GerardinEmilie JouanjusFrédéric Libertnull nullMarylène GuerlaisCaroline Victorri-Vigneau
Published in: European journal of public health (2023)
Further monitoring is needed in light of these persistent markers of problematic consumption.
Keyphrases
  • chronic pain
  • quality improvement
  • transcription factor
  • intimate partner violence
  • adverse drug
  • drug induced